相关实验视频
Updated: May 22, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.5K
在非危急病患者的肠道营养中,高血糖相关的风险因素
Esther Delgado-García1, Juan José López-Gómez1, Rebeca Jiménez-Sahagún1
1Hospital Clínico Universitario de Valladolid, Universidad de Valladolid, Valladolid, Spain; Centro de Investigación en Endocrinología y Nutrición (IENVA), Universidad de Valladolid, Valladolid, Spain.
Endocrinologia, diabetes y nutricion
|March 14, 2025
概括
接受肠道营养 (EN) 的住院患者经常经历碳水化合物代谢变化. 晚年和更长的营养治疗时间是EN期间高血糖症的关键风险因素.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 临床营养学 临床营养学
- 患者护理 患者护理
背景情况:
- 接受压力或肠道营养 (EN) 的住院患者容易发生碳水化合物代谢变化.
- 识别这些代谢变化的触发因素对于有效的患者管理至关重要.
研究的目的:
- 调查与接受EN.的非糖尿病患者碳水化合物代谢失调相关的风险因素.
- 为了确定患者高血糖的患病率在EN.
主要方法:
- 对131名非糖尿病患者进行了回顾性观察性研究,这些患者在EN上有低压力水平.
- 患者根据pre-EN血糖 (压力高血糖与非高血糖) 和EN期间的血糖 (高血糖与EN与非高血糖) 进行分类.
主要成果:
- 在EN期间观察到高患高血糖率 (71%).
- 患者年龄 (OR,1.186) 和营养治疗的持续时间 (OR,1.320) 被确定为高血糖症的重要危险因素.
- 52名患者超过180mg/dL,其中24人需要胰岛素.
结论:
- 碳水化合物代谢障碍在住院患者中很常见.
- 患者年龄的增加和营养治疗的延长时间是EN期间患上高血糖症的主要危险因素.
相关概念视频
Hypoglycemia and Glucagon
146
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
146
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
53
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
53
Enteral Nutrition I: Orogastric and Nasogastric Feeding
159
Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
159
Oral Hypoglycemic Agents: Glinides
124
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
124
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications
495
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495

